Annual
Report
2015
Table of Contents
Message from the Chair .................................................... 3
TakPAC Officers .................................................................. 4
TakPAC Relaunch ............................................................... 5
Message from the Treasurer ............................................ 6
Transparency in the Political Process .............................. 8
Who We Support ................................................................ 8
Political Contribution Rankings Among
Pharmaceutical Companies ............................................. 13
YOUR VOICE IN PUBLIC
POLICY TO IMPROVE
PATIENT LIVES
2
2015 TakPAC Annual Report
www.TakedaPAC.com
Message
from the
Chair
Dear Takeda Colleagues,
As you know, Takeda operates in a highly
regulated industry. It is imperative that Takeda
be a part of the public policy and legislative
process. TakPAC is an essential tool to support
candidates who share our goal to provide
better health for people worldwide through
leading innovation in medicine.
As the new Chair of TakPAC, I am excited to
highlight the many changes that are happening
with Takeda’s political action committee. One
of my priorities during the next few months is
to enhance communications around TakPAC
activity with both current members and
prospective eligible supporters1 by providing
regular email updates, newsletters, election
bulletins, and events. Our goal is to provide
meaningful information that will encourage
increased engagement in the political process.
TakPAC is funded entirely through voluntary
contributions from eligible Takeda employees.
Every member of TakPAC has joined a team of
dedicated professionals that drive innovation
and support the pharmaceutical industry. Many
thanks for your leadership and commitment to
Takeda, our industry, and our patients.
TakPAC serves to amplify our voice in policy
debates at the state and federal levels that
affect all of us.
Sincerely,
TakPAC is committed to transparency related
to the political process. As Chair, I’m pleased
to offer members a retrospective of our 2015
activity. This Annual Report provides detailed
financial statements, a complete list of TakPAC
political contributions, a highlight of policy and
legislative action and comparison data to best
understand how TakPAC ranks against others
in the industry.
Rick Ascroft
TakPAC Chairman
Vice President, Managed Markets
and Government Affairs
1 T he Federal Election Commission regulations define eligible employees as “executive or administrative personnel” who are paid a
salary and exercise policymaking, managerial, professional or supervisory responsibilities. See 11 C.F.R. § 114.1(c).
3
2015 TakPAC Annual Report
www.TakedaPAC.com
Political Engagement
ADVANCING OUR AGENDA
A
Government actions such as price controls,
pharmaceutical manufacturer rebates and
limiting access to Takeda’s medicines affect our
ability to invest in innovation. Takeda, through
its Government and External Affairs function,
helps inform the U.S. debate over healthcare
and pharmaceutical innovation at the federal,
state and local levels. Within GEA’s framework,
TakPAC plays a crucial role in these ongoing
debates. In supporting political candidates who
understand the importance of the work the
biopharmaceutical industry does every day, we
seek to create an environment where the needs
of our patients and our industry can be heard.
Issues like patient access, reward for innovation,
regulatory reform, market-based solutions and
ensuring appropriate incentives for investment
are vital to moving Takeda forward.
s a research-based global pharmaceutical
company with a strong commitment
to developing and marketing
innovative medicines for therapeutic areas with
significant unmet needs, it is imperative that
Takeda has multiple opportunities to engage
with U.S. policymakers and policy influencers
in healthcare and related public policy debates.
The U.S. government accounts for nearly
half of all U.S. healthcare spending, and its
policies, legislation and regulations impact the
entire healthcare system. In order to ensure
that Takeda’s point of view is considered by
policymakers in critical debates affecting our
products and therapeutic areas, we must
provide a regular stream of information over
time to educate those elected officials on both
sides of the aisle. Political contributions are
one additional tool to ensure that our views
are heard by those who make decisions in the
largest pharmaceutical market in the world.
2015 TAKPAC OFFICERS & TEAM
CHAIR
VICE CHAIR
TREASURER
ASSISTANT TREASURER
TEAM MEMBER
TEAM MEMBER
RICHARD
ASCROFT
LAURA
CLINE
HELEN
GIZA
PATRICK
BUTLER
SHELLEY
STEWART
STEVE
KERMISCH
Vice President,
Managed Markets
and Government
Affairs
Senior Director,
Federal Government
and External Affairs
Vice President,
Finance
Senior Director,
Taxation
Federal Government
Affairs Director
Senior Director,
State Government
Affairs
4
2015 TakPAC Annual Report
www.TakedaPAC.com
TakPAC Relaunch
A STRONGER VOICE FOR TAKEDA AND OUR PATIENTS
I
n 2015, we prepared to re-launch TakPAC
and revitalize our approach to make it more
meaningful for our members and eligible
colleagues, who will continue to receive
valuable information and resources as we strive
to make TakPAC a stronger voice for Takeda,
our industry and the patients we serve.
discussions on Capitol Hill and in state capitals
across the country. Our elected leaders need
to know how their decisions and policies will
impact the health of patients in their district
or state.
Driven by our commitment to integrity and
mission statement to “strive towards better
health for people worldwide through leading
innovation in medicine,” we began the work to
relaunch TakPAC. Our motivation concentrated
on three pillars—Patients, Innovation and
being an Industry Driver. The goal of this
makeover is to provide current TakPAC donors
with a new clearinghouse of information on
political advocacy activities while educating
prospective, eligible members on the benefits
of participating in the political process.
Takeda employees strive towards better
health for people worldwide through leading
innovation in medicine. Through TakPAC, we
build strong relationships with lawmakers to
help ensure their policies and proposals protect
our ability to continue to innovate for patients
in need. Our new approach will help colleagues
understand the value of these relationships
and why we maintain them.
INNOVATION
INDUSTRY DRIVER
Takeda and its employees strive to lead in
medical innovation, but also to propel the
pharmaceutical industry as a whole to lift the
burden of disease for patients around the
world. TakPAC seeks to drive the healthcare
debate to help shape policies and support
these innovations that benefit our patients.
PATIENTS
Many issues drive our political activities. Takeda
puts patients at the center of everything we
do, from the research and development to the
launch and sale of products. And rightly so—it
is our goal to create value to achieve the unmet
medical needs of patients all over the globe.
TakPAC also takes this patient-centric approach
to be the voice for patients in public policy
5
2015 TakPAC Annual Report
www.TakedaPAC.com
Message
from the
Treasurer
Dear Takeda Colleagues,
As in years past, TakPAC was able to engage
eligible colleagues to support elected officials
at both the state and federal levels. TakPAC
received support from 135 members who
contributed a total of $60,218.71, with an
average annual contribution of $446.06.
TakPAC made contributions to 48 state and
federal candidates and committees last year
totaling $97,000. With a presidential election
on the horizon and critical races in both
Washington, D.C. and in state capitals, there is
more work to be done.
contribution per member. TakPAC participation
remained close to previous year’s totals.
Looking ahead, we are confident that this
trend will be addressed with a multi-pronged
and impactful education campaign that
focuses on keeping current members up-todate on advocacy activities while empowering
prospective, eligable donors with information
about TakPAC and the value of participating in
the political process.
Sincerely,
As we think about opportunities to enhance
and grow TakPAC, it is important to analyze
the previous year’s activity. 2015 saw a slight
decline in funds raised and average annual
Helen Giza
TakPAC Treasurer
Vice President, Finance
135
$446
$97,000
MEMBER
CONTRIBUTIONS
AVERAGE ANNUAL
CONTRIBUTION
PER MEMBER
2015 TOTAL
DISBURSEMENTS TO:
48 STATE AND FEDERAL
CAMPAIGN COMMITTEES
6
2015 TakPAC Annual Report
www.TakedaPAC.com
Treasurer’s Report
A YEAR OF TRANSITION
Receipts
Contributions
$60,218.71
Interest Income
$0.00
Reimbursed Operating Expenses
$0.00
Reimbursed to Contributors
$0.00
Total Receipts
$60,218.71
Expenditures
Candidate Contributions
$63,500.00
Committee Contributions
$33,500.00
In-Kind Contributions
$0.00
Operating Expenses
$1,556.30
Total Expenditures
$98,556.30
Cash Balance
Beginning balance January 1, 2015
$78,884.17
Total Receipts
$60,218.71
Total Disbursements
$98,556.30
Ending Balance December 31, 2015
$40.546.58
7
2015 TakPAC Annual Report
www.TakedaPAC.com
Transparency in the
Political Process
T
akeda Pharmaceuticals and TakPAC are
committed to transparency in the political
process at both the state and federal
levels. Where required, Takeda reports both
lobbying activity and disbursement of political
funds to candidates at state and federal levels.
Takeda also files quarterly lobbying reports
that capture federal lobbying activity in the
U.S. House and Senate and with any federal
agencies. Takeda’s lobbying reports can be
found at http://lobbyingdisclosure.house.gov.
TakPAC is a separate, segregated fund that is
registered with the Federal Election Commission
as a multi-candidate political action committee
connected with Takeda Pharmaceuticals
America. The committee is a Lobbyist/Registrant
PAC. TakPAC is a quarterly filer, reporting activity
four times per year with additional reporting
requirements during election years. TakPAC
reports are publicly available and can be found
at www.fec.gov.
The purpose of the Takeda Political Action
Committee (TakPAC) is to provide monetary
contributions and other support to candidates
for federal, state, and local offices. Only eligible
employees may contribute to TakPAC. Eligible
employee participation in TakPAC is completely
voluntary, all contribution guidelines are only
suggestions, and eligible employees are free
to contribute more or less than the guidelines
or nothing at all. Takeda will neither favor nor
disadvantage any eligible employee by reason of
the amount of his or her contribution or decision
not to contribute. Eligible employees may refuse
to contribute without reprisal.
8
2015 TakPAC Annual Report
www.TakedaPAC.com
Who We
Support
TakPAC, its Officers and the Takeda Government Affairs team
consider many criteria when making a political contribution to
an elected official or candidate.
These criteria include:
• The candidate’s interest or involvement in the pharmaceutical industry and
his or her positions on key issues affecting Takeda and our patients
• The presence of Takeda facilities, employees and major customers in the
candidate’s district/state
• The candidate’s leadership and membership on key committees with
jurisdiction over legislative issues affecting Takeda and our patients
• The candidate’s character, integrity and leadership positions
• The candidate’s financial need and the nature of the opposition
9
2015 TakPAC Annual Report
www.TakedaPAC.com
Disbursements
Summary
FEDERAL DISBURSEMENTS
CANDIDATE/PARTY
STATE
Carper for Senate
Sen. Thomas Carper (D)
DE
$2,500
Kirk for Senate
Sen. Mark Kirk (R)
IL
$2,500
Friends of Susan Brooks
Rep. Susan Brooks (R)
IN
$2,500
Capuano for Congress Committee
Rep. Michael Capuano (D)
MA
$1,000
Davis for Congress/Friends of Davis
Rep. Danny Davis (D)
IL
$5,000
Rodney for Congress
Rep. Rodney Davis (R)
IL
$1,000
Dold for Congress
Rep. Robert Dold (R)
IL
$2,500
Bill Foster for Congress
Rep. Bill Foster (D)
IL
$1,000
Gene Green Congressional Campaign
Rep. Gene Green (D)
TX
$2,500
Guthrie for Congress
Rep. S. Brett Guthrie (R)
KY
$1,000
Mike Honda for Congress
Rep. Michael Honda (D)
CA
$1,000
Randy Hultgren for Congress
Rep. Randy Hultgren (R)
IL
$1,000
Kind for Congress Committee
Rep. Ronald Kind (D)
WI
$5,000
Kinzinger for Congress
Rep. Adam Kinzinger (R)
IL
$1,000
People for Ben
Rep. Ben Lujan (D)
NM
$5,000
Moulton for Congress
Rep. Seth Moulton (D)
MA
$1,000
Napolitano for Congress
Rep. Grace Napolitano (D)
CA
$1,000
Richard E. Neal for Congress Committee
Rep. Richard Neal (D)
MA
$1,000
Friends of Erik Paulsen
Rep. Erik Paulsen (R)
MN
$2,500
Scott Peters for Congress
Rep. Scott Peters (D)
CA
$5,000
John S. Fund
Rep. John Shimkus (R)
IL
$1,000
Walden for Congress
Rep. Gregory Walden (R)
OR
$1,000
TOTAL
AMOUNT
$47,000
10
2015 TakPAC Annual Report
www.TakedaPAC.com
Disbursements
Summary
STATE DISBURSEMENTS
CANDIDATE/PARTY
STATE
Carol Alvarado Campaign
Rep. Carol Alvarado (D)
TX
$500
Cesar Blanco Campaign
Rep. Cesar Blanco (D)
TX
$500
Citizens for Brown
Rep. Tim Brown (R)
OH
$500
Nicole Collier Campaign
Rep. Nicole Collier (D)
TX
$500
Sarah Davis Campaign
Rep. Sarah Davis (R)
TX
$500
Friends of Faber
Sen. Keith Faber (R)
OH
$2,000
Citizens for Anne Gonzales
Rep. Anne Gonzales (R)
OH
$1,000
Kelly Hancock Campaign
Sen. Kelly Hancock (R)
TX
$1,000
Juan Hinojosa Campaign
Sen. Juan Hinojosa (D)
TX
$1,000
Friends of Shannon Jones
Sen. Shannon Jones (R)
OH
$1,000
Lois Kolkhorst Campaign
Sen. Lois Kolkhorst (R)
TX
$1,000
Trey Martinez Fischer Campaign
Rep. Trey Martinez Fischer (D)
TX
$1,000
Robert Nichols Campaign
Sen. Robert Nichols (R)
TX
$1,000
Eddie Rodriguez Campaign
Rep. Eduardo Rodriguez (D)
TX
$500
Texans for Charles Schwernter
Sen. Charles Schwertner (R)
TX
$1,000
Citizens for Sears
Rep. Barbara Sears (R)
OH
$500
Friends of Ryan Smith
Rep. Ryan Smith (R)
OH
$1,000
Van Taylor Campaign
Sen. Van Taylor (R)
TX
Carlos Uresti Campaign
Sen. Carlos Uresti (D)
TX
$750
Judith Zaffirini Campaign
Sen. Judith Zaffirini (D)
TX
$1,000
John Zerwas Campaign
Rep. John Zerwas (R)
TX
$500
TOTAL
AMOUNT
$750
$17,500
11
2015 TakPAC Annual Report
www.TakedaPAC.com
Disbursements
Summary
NON-CANDIDATE DISBURSEMENTS
AMOUNT
Committee for Hispanic Causes/Building Our
Leadership Diversity PAC (CHC BOLD PAC)
$5,000
New Democrat Coalition PAC
$5,000
National Republican Congressional
Committee
$15,000
Republican Mainstreet Partnership PAC
$5,000
Value in Electing Women Political Action
Committee
$2,500
TOTAL
$32,500
GRAND TOTAL
$97,000
Federal Contributions
Democratic Party
Committees
13%
Senate
Democrats
3%
House
Democrats
36%
Federal Contributions by Party
Republican Party
Committees
28%
Senate
Republicans
3%
House
Republicans
17%
12
Democratic
Party
52%
Republican
Party
48%
2015 TakPAC Annual Report
www.TakedaPAC.com
Political Contribution
Rankings Among
Pharmaceutical Companies
2015 TOP 21 COMPANIES GLOBALDATA*
Takeda
Eisai
Daiichi Sankyo
F. Hoffman-La Roche
Baxter
Teva
Boehringer Ingelheim
Astellas
Bayer
Bristol-Myers Squibb
Novartis
Novo Nordisk
GlaxoSmithKline
Johnson & Johnson
Sanofi
AstraZeneca
AbbVie
Merck
Amgen
Lilly
Pfizer
$60,219
$70,618
$78,765
$86,757
$117,186
$137,687
$155,135
$160,462
$228,297
$255,745
$265,412
$356,402
$492,521
$571,842
$770,717
$782,485
$820,670
$948,670
$1,005,785
$1,014,001
$1,512,364
*Rankings are by GlobalData based on figures for
2014, 2013, 2012 and 2011 global sales revenue.
13
2015 TakPAC Annual Report
www.TakedaPAC.com
Political Contribution
Rankings Among
Pharmaceutical Companies
42%
42%
Pfizer
GSK
58%
58%
%
52
Takeda
45%
48%
AbbVie
55%
Baxter
Republican
55%
Democrat
14
45%
2015 TakPAC Annual Report
www.TakedaPAC.com
One Takeda Parkway
Deerfield, IL 60015
[email protected]
www.TakedaPAC.com
The purpose of the Takeda Political Action Committee (TakPAC) is to
provide monetary contributions and other support to candidates for
federal, state and local offices. Employee participation in TakPAC is
completely voluntary, all contribution guidelines are only suggestions
and employees are free to contribute more or less than the guidelines
or nothing at all. Takeda will neither favor nor disadvantage any
employee by reason of the amount of his or her contribution or decision
not to contribute. Employees may refuse to contribute without reprisal.